Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The company also focuses on the development of surgical robotics and medical devices; and operating outpatient clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in Central, Hong Kong.

2.5 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

Aptorum Group has received 50.67% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Aptorum Group and other stocks. Vote “Outperform” if you believe APM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe APM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Miscellaneous

Receive APM News and Ratings via Email

Sign-up to receive the latest news and ratings for APM and its competitors with MarketBeat's FREE daily newsletter.

Aptorum Group (NASDAQ:APM) Frequently Asked Questions

How has Aptorum Group's stock been impacted by COVID-19 (Coronavirus)?

Aptorum Group's stock was trading at $2.93 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, APM stock has increased by 14.3% and is now trading at $3.35. View which stocks have been most impacted by Coronavirus.

When is Aptorum Group's next earnings date?

Has Aptorum Group been receiving favorable news coverage?

Media headlines about APM stock have been trending extremely negative this week, InfoTrie reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Aptorum Group earned a news sentiment score of -5.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the immediate future. View the latest news aboutAptorum Group.

Are investors shorting Aptorum Group?

Aptorum Group saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 16,600 shares, a decline of 5.7% from the April 30th total of 17,600 shares. Based on an average trading volume of 32,400 shares, the days-to-cover ratio is presently 0.5 days. Approximately 0.3% of the shares of the company are sold short. View Aptorum Group's Current Options Chain.

What is Aptorum Group's stock symbol?

Aptorum Group trades on the NASDAQ under the ticker symbol "APM."

How do I buy shares of Aptorum Group?

Shares of APM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aptorum Group's stock price today?

One share of APM stock can currently be purchased for approximately $3.35.

How big of a company is Aptorum Group?

Aptorum Group has a market capitalization of $97.05 million and generates $540,000.00 in revenue each year. Aptorum Group employs 39 workers across the globe.